Krystal Biotech, Inc. (KRYS)
269.48
-3.27
(-1.20%)
USD |
NASDAQ |
Apr 28, 16:00
269.48
0.00 (0.00%)
After-Hours: 20:00
Krystal Biotech Research and Development Expense (TTM) : 55.08M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Scholar Rock Holding Corp. | 206.78M |
| Stoke Therapeutics, Inc. | 136.15M |
| Regeneron Pharmaceuticals, Inc. | 5.306B |
| Alnylam Pharmaceuticals, Inc. | 1.320B |
| TG Therapeutics, Inc. | 160.22M |